Conditional Disease-Free Survival After Surgical Resection of Gastrointestinal Stromal Tumors
Author(s) -
Danielle A. Bischof,
Yuhree Kim,
Rebecca M. Dodson,
M. Carolina Jimenez,
Ramy Behman,
Andrei Cocieru,
Sarah B. Fisher,
Ryan T. Groeschl,
Malcolm H. Squires,
Shishir K. Maithel,
Dan G. Blazer,
David A. Kooby,
T. Clark Gamblin,
Todd W. Bauer,
Fayez A. Quereshy,
Paul J. Karanicolas,
Calvin Law,
Timothy M. Pawlik
Publication year - 2015
Publication title -
jama surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.757
H-Index - 176
eISSN - 2168-6262
pISSN - 2168-6254
DOI - 10.1001/jamasurg.2014.2881
Subject(s) - medicine , gist , nomogram , concordance , cancer , cohort , retrospective cohort study , disease , colorectal cancer , oncology , surgery , stromal cell
Gastrointestinal stromal tumors (GISTs) are the most commonly diagnosed mesenchymal tumors of the gastrointestinal tract. The risk of recurrence following surgical resection of GISTs is typically reported from the date of surgery. However, disease-free survival (DFS) over time is dynamic and changes based on disease-free time already accumulated following surgery.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom